We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mirion Technologies Inc | NYSE:MIR | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-3.13 | -17.31% | 14.9753 | 16.80 | 14.43 | 16.80 | 5,781,850 | 00:53:06 |
Mirion (NYSE: MIR) announced today that its management team’s presentation at Jefferies’ 2024 Global Healthcare Conference will now begin at 3:30 PM ET on Thursday, June 6, 2024.
The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event.
About Mirion
Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604787612/en/
For investor inquiries, please contact: Jerry Estes ir@mirion.com
1 Year Mirion Technologies Chart |
1 Month Mirion Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions